RUNX1 Familial Platelet Disorder Latest Advances
Find the Latest Research About RUNX1 Familial Platelet Disorder
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1043 publications
Cholangiocyte RUNX1 Orchestrates Fibrogenic and Inflammatory Signaling to Drive Biliary Fibrosis.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2026
RUNX1 and YY1 modulate neuronal fate and energy metabolism in Alzheimer's disease.
Journal: bioRxiv : the preprint server for biology
Published: April 27, 2026
RUNX1 Alterations in Pediatric Myeloid Malignancies: Divergent Germline and Somatic Trajectories.
Journal: International journal of molecular sciences
Published: April 16, 2026
Acute degron-mediated RUNX1 loss reprograms enhancer activity to epigenetically drive epithelial destabilization and initiate cancer hallmarks.
Journal: bioRxiv : the preprint server for biology
Published: April 03, 2026
Impact of U2AF1 Pathogenic Variants on Prognosis of Myelodysplastic Neoplasms With RUNX1 Mutation.
Journal: Hematological oncology
Published: February 25, 2026
Multidimensional immune ecological subtyping identifies RUNX1 as a prognostic factor in uveal melanoma.
Journal: Discover oncology
Published: February 15, 2026
Impact of RUNX1 mutations at distinct sites on the clinical characteristics and prognosis of patients with acute myeloid leukemia.
Journal: BMC cancer
Published: January 02, 2026
A genetic architect of opioid responses: Microglial Runx1.
Journal: Neuron
Published: December 31, 2025
Immunophenotypic, Genetic, and Clinical Features Associated With RUNX1 Mutation in Acute Leukemias and Chronic Myeloid Neoplasms.
Journal: International journal of laboratory hematology
Published: November 26, 2025
Multi-omics reveals rutin directly targets RUNX1 to disrupt the RUNX1/TET2 complex and alleviate NAFLD via TLR4/NF-κB inhibition.
Journal: European journal of pharmacology
Published: November 24, 2025
Last Updated: 06/30/2026